HLA-ABC antibody (PE-Cy5)
Quick Overview for HLA-ABC antibody (PE-Cy5) (ABIN7470008)
Target
See all HLA-ABC AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
- 
    
- 
                                            
Isotype
 - IgG2a, kappa
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Application Notes
 - Optimal working dilution should be determined by the investigator.
 - 
                                            
Comment
 - 
                        
Matching Isotype Control: PE/Cyanine5 Mouse IgG2a, κ Isotype Control (ABIN7469780)
 - 
                                            
Restrictions
 - For Research Use only
 
 - 
                                            
 - 
    
- 
                                            
Buffer
 - PBS with 0.05 % Proclin300, 1 % BSA
 - 
                                            
Preservative
 - ProClin
 - 
                                            
Precaution of Use
 - This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 - 
                                            
Storage
 - 4 °C
 - 
                                            
Storage Comment
 - Store at 2~8°C and protected from prolonged exposure to light. Do not freeze.
 
 - 
                                            
 - 
    
- HLA-ABC
 - 
                                            
Alternative Name
 - HLA-A,B,C
 - 
                                            
Background
 - Major Histocompatibility Class I, MHC class I,MHC class I antigens associated with β2-microglobulin are expressed by all human nucleated cells. MHC class I molecules are involved in presentation of antigens to CD8+ T cells. They play an important role in cell-mediated immune responses and tumor surveillance.
 - 
                                            
Gene ID
 - 3105
 - 
                                            
UniProt
 - P04439, P01889, P10321
 - 
                                            
Pathways
 - TCR Signaling, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
 
Target
 -